UK Implements Major Clinical Trial Regulatory Overhaul
英國實施臨床試驗法規重大改革
On April 28, 2026, the United Kingdom launched a historic overhaul of its clinical trial regulations, marking the most significant change in two decades.
2026年4月28日，英國對其臨床試驗法規進行了歷史性的全面改革，標誌著二十年來最重大的變革。
Driven by the need to reverse declining enrollment rates and boost life sciences, these reforms aim to cut red tape while keeping safety at the forefront.
基於扭轉註冊率下滑並促進生命科學發展的需求，這些改革旨在精簡行政程序的同時，維持安全性作為首要考量。
Furthermore, the new rules mandate transparency, requiring researchers to register trials publicly and share plain-language results with participants.
此外，新規則強制要求透明化，要求研究人員公開註冊試驗並與參與者分享淺顯易懂的研究結果。
As the UK charts its own path post-Brexit, it is intentionally opting for a sovereign regulatory framework rather than relying on EU systems.
隨著英國在脫歐後自行規劃路徑，它選擇採取主權監管框架，而非依賴歐盟系統。
